Advanced injectable drug delivery system: A brief review
Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2016, Vol 4, Issue 4
Abstract
In modern therapeutics the controlled/sustained release dosage forms have become extremely popular. Development of sustained release injectable has occurred in the past few years. This was brought into existence to prolong the effect of drug at targeted site. This advancement also offers reducing dosing frequency, maximizing the efficacy dose relationship, decreasing adverse side effects and enhancing patient compliance. The Parenteral administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. But parenteral route offers rapid onset of action with rapid declines of systemic drug level. For the sake of effective treatment it is often desirable to maintain systemic drug levels within the therapeutically effective concentration range for as long as treatment calls for. It requires frequent injection, which ultimately leads to patient discomfort. For this reason, drug delivery system which can reduce total number of injection throughout the effective treatment, improve patient compliance as well as pharmacoeconomic. Parenteral drug delivery with intravenous, subcutaneous or intramuscular injection can gain easy access to systemic circulation with rapid drug absorption. For the sake of effective treatment it is often desirable to maintain systemic drug levels within the therapeutically effective concentration range for as long as treatment calls for. This review focused on the brief discussion on the latest injectable controlled released dosage forms.
Authors and Affiliations
Aijaz A. Sheikh
Keywords
Related Articles
- EP ID EP567620
- DOI -
- Views 107
- Downloads 0
Process development, evaluation and controlling of parameters during formulation development of Loratadine as an ODT by QBD concept
Quality by design (QbD) refers to an advanced approach toward drug development. QbD is a vital part of the modern approach to pharmaceutical quality. There is much confusion among pharmaceutical scientists in generic dru...
Antidepressant activity of “Cissampelos pareria” extract in mice
Depression is a wide spread psychiatric disorder affecting around 5% of the population and it is difficult to predict the patient response to any given treatment. The present study aimed at studying the pharmacological a...
Formulation and development of orodispersible tablets of lornoxicam by using resinate inclusion complexes
Lornoxicam is a non-steroidal anti-inflammatory drug and it belongs to the class of oxicam. It is used for potent inhibitor of both COX-1 and COX-2. But it is a very bitter drug and insoluble in water. Aim: To mask the t...
Microwave assisted novel synthesis and biological evaluation of 1- (Substituted phenyl)-2-phenyl-4-(Substituted benzylidene)-imidazole-5- ones
A series of 5-substituted imidazolones 1-20 analogs were prepared by the condensation of different substituted 5-oxazolone analogs with various aromatic amines by using microwave irradiations. The structures of all the n...
Peroxisome proliferator-activated receptor-alpha agonists in the management of the diabetic acute kidney injury: Is the verdict out?
The growing evidences of diabetic acute kidney injury (AKI) suggested that diabetes is one of the detrimental causes. AKI is associated with glomerular hypertrophy, glomerulosclerosis, tubulointerstitial fibrosis, and me...